What's new

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Feb 11, 2025 - 16:50
 0
Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

SWTCH Energy selected to power 2500 EV chargers in 136 Greystar Properties acros...

Next Article

Can the solar industry police itself?

Related Posts

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Herbal medicinal product: Anisi fructusArray, C: ongoing call for scientific data

Herbal medicinal product: Anisi fructusArray, C: ongoin...

Feb 14, 2025  0

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 5 December 2024, 09:30 (CET) to 5 December 2024, 13:30 (CET)

Meeting of the Medicine Shortages Single Point of Conta...

Feb 10, 2025  0